SlideShare a Scribd company logo
CARBON
MONOXIDE
POISONING
Dr. DAMINENI RAVI TEJA
EMERGENCY MEDICINE
INTRODUCTION
● Carbon Monoxide poisoning occurs after breathing in excessive levels of carbon monoxide
● It is released into the environment by the incomplete combustion of carbonaceous
materials
EPIDEMIOLOGY
● Carbon Monoxide may be responsible for 50% of all fatal poisonings
● Carbon Monoxide poisoning victims dies before reaching the hospital ,of those
hospitalised, approximately 2% die, 10%recovery partially , and 23% to 47% suffer
delayed neurologic sequelae
SOURCES OF EXPOSURE
CO is produced from incomplete combustion of fuels. Potential sources of CO include:
● Smoke inhalation from fires
● Poorly functioning heating systems
● Improperly vented fuel-burning devices
● Motor vehicles operating in poorly ventilated areas
● Open air exposure to motorboat exhaust
● Underground electrical cable fires that produce large amounts of CO, which can seep into
adjacent buildings and homes
● Inhaled or ingested methylene chloride
PATHOPHYSIOLOGY
● Normal physiologic CO levels (as carboxyhemoglobin) from this process are approximately
1% in healthy nonsmokers.
● Physiologic production can be increased in hemolysis or sepsis.
● CO toxicity causes profound tissue hypoxia and activation of inflammatory mediators that
may lead to permanent injury of the heart, the CNS and less commonly, the peripheral
nervous system
CO enters the body via lungs
Direct interactions damages the lung parenchyma
In the body CO is delivered by Hb
CO causes capillary leakage of macromolecules from the lungs and systemic vasculature
This can occur in humans who have been exposed to relatively low concentration
As Carboxyhemoglobin(COHgb) levels rises
Cerebral blood vessels dilate, and both coronary blood flow and capillary density increases
If exposure continues, central respiratory depression develops which may result from cerebral hypoxia
Cardiac effects VENTRICULAR arrhythmias occur
Ventricular arrhythmias are implicated as the cause of death most often in CO poisoning
There is evidence that myocardial impairment begins at the relatively low level of COHgb of
20%
The overall cause of death for CO poisoning is combined hypoxia and ischemia during the acute
events
Tissue hypoxia
● Approx 85% of CO is bound to HB
● Rest dissolve in plasma or bound intracellularly
often to myoglobin
● CO shift the oxyhemoglobin dissociation curve to
left,imparin 02 release to tissues
● Half life of COHb on RA ranges b/w 249-320 min
● On 100% 02 AP ½ life is about 74-80 min
● ½ life of METHYLENE CHLORIDE exposure >
8 hrs due to metabolic production
OXYGEN TENSION 150 mm Hg
HbO2
%
sat
0
100%
Mitochondrial inhibition
CO binds as ferrous heme A3
disabling oxidative phosphorylation
(more under the hypoxic conditions)
● Decreases adenosine triphosphate production
● production of free radicals
● compromising tissues with the highest metabolic demand(brain & heart)
● generating lactic acidosis
CO activates
By displacing NO reacts with superoxide
Platelets
Peroxynitrite
Compromise mitochondrial functions
Platelets activation
To yield
further
stimulates
Inflammatory and platelets effects
the combined effect
Neutrophil to degenerate
Myeloperoxidase further degranulation
stimulates
releases
amplifying
&
Platelet activation
Proinflammatory mediators
catalyze
Lipid peroxidation of myelin proteins of nerves tissues
triggering
&
microglia (primarily of the CNS)
Cells are more sensitive to this neurotoxic effect
lymphocytes
Demonstrate GLOBUS PALLIDUS lesion Evident in CT/MRI
Platelet activation
endothelial injury &
cell apoptosis combine
to yield several types of
cardiac injury or dysfunction
CARBOXYHEMOGLOBIN MEASUREMENT
● Co-oximetry, which measures total hemoglobin as well as oxyhemoglobin, methemoglobin,
and COHb saturation, is the only accurate measurement tool.
● venous blood gas with co-oximetry is sufficient in most cases.
TOXICODYNAMICS
● Carbon monoxide has ~210 times the affinity for haemoglobin than oxygen.
● Binding Therefore renders haemoglobin oxygen carrying capacity and delivery to the
tissues.
● This can result in tissue hypoxia and ischaemic injury.
● CO also binds to intracellular cytochromes, impairing aerobic metabolism
● Carbon monoxide also triggers endothelial oxidative injury, lipid peroxidation and an
inflammatory cascade
● These mechanisms are probably responsible for delayed neurological sequelae
Typical clinical symptoms and signs relative to COHb
● <10% (nil, commonly found in smokers)
● 10 – 20% (nil or vague nondescript symptoms)
● 30 – 40% (headache, tachycardia, confusion, weakness, nausea, vomiting, collapse)
● 50 – 60% (coma, convulsions,Cheyne-Stokes breathing, arrhythmias, ECG changes)
● 70 – 80% (circulatory and ventilatory failure, cardiac arrest, death)
TOXICOKINETICS
● Absorption:
● COHb concentration in blood is a function of the CO concentration in inspired air and the
time of exposure
● Clinical effects occur within 2 hours of exposure at concentrations as low as 0.01% (100
ppm)
● Uptake (and elimination) of CO is increased by:
● Decreased barometric pressure
● increased activity
● increased rate of ventilation
● high metabolic rate
● Anaemia
● Tobacco smokers have higher baseline concentrations of COHb (3 to 10%) and therefore
will reach toxic concentrations earlier in any exposure
● Distribution:
● Rapidly binds available haemoglobin
● Metabolism:
● <1% of the absorbed CO is metabolised endogenously to carbon dioxide
Elimination:
● CO is eliminated unchanged from the lungs in an exponential manner
● The biological half-life of CO in a sedentary healthy adult is 4–5 hours
● This half-life decreases with oxygen administration
● ~ 40–80 minutes with administration of 100% oxygen
● ~ 23 minutes with hyperbaric oxygen (2 atmospheres)
● elimination is affected by the factors as absorption and is likely faster in many CO
poisoned patients due to compensatory measures (e.g. hyperventilation,increased cardiac
output)
ACUTE POISONING
● CNS:Headache,nausea,dizziness,confu
sion,AMS,ataxia,seizures and finally
comma
● CVS: Dysrhythmias,Ischaemia,hyper
or hypotension
● GI:Abdominal Pain,
Nausea+Vomiting, Diarrhoea
● RS: Dyspnea,Tachycardia,Chest Pain,
Palpitation
CHRONIC POISONING
● Headache
● Personality changes
● Poor Concentration
● Dementia, Psychosis
● Parkinsonism
● Ataxia
● Peripheral Neuropathy and
● Hearing loss
CLINICAL FEATURES
INVESTIGATIONS
ABG:
● HbCO (elevated levels are significant, but low levels do not rule out exposure)
● lactate (tissue hypoxia)
● PaO2 should be normal, SpO2 only accurate if measured (not calculated from PaO2)
● MetHb (exclude)
ECG:
● sinus tachycardia, ischaemic changes
Urinalysis
● positive for albumin and glucose in chronic intoxication
IMAGING
Radiographic features:
● Changes tend to be bilateral with the
globus pallidus most commonly
affected.
CT:
● Classically seen as low attenuation in
the globus pallidus region. Other
features include diffuse
hypoattenuation in cerebral white
matter.
LABORATORY
● CBC (mild leukocytosis)
● BSL (hyperglycaemia)
● UEC (hypokalaemia, acute renal failure from myoglobinuria)
● CK (rhabdomyolysis)
● LFT derangement (ischaemia)
● ethanol level (polypharmacy OD)
● cyanide level (industrial fire, cyanide exposure)
TREATMENT
LOW-RISK FEATURES
● If CO poisoning is suspected, start
100% oxygen immediately.
● Identify risks for possible referral for
hyperbaric oxygen treatment
HIGH-RISK FEATURES
● HBO2 [hyperbaric oxygen] therapy or
high-flow normobaric therapy for
acute CO-poisoned patients
● role is uncertain
● 3 atmospheres will decrease the half life of carboxyHb from 6 hours to ~ 24 minutes
often considered for therapy if:
● All pregnant patients
● Significant LOC
● Signs of ischaemia
● Significant neurological deficit
● Metabolic acidosis
contra-indications:
● chest trauma
● other major comorbidity or acute instability (e.g. serious drug overdose, severe burns)
● uncooperative patient
complications:
● decompression sickness
● rupture of tympanic membranes
● damaged sinuses
● oxygen toxicity
● problems due to lack of monitoring
DISPOSITION
● Those without any high-risk features of CO intoxication may be discharged from the ED
after symptom resolution and normalization
● If there is a suspected source of environmental CO, other potentially exposed persons
should be contacted and evaluated in the ED
● Patients with accidental or inadvertent CO exposure should be referred for cognitive
follow-up in 4 to 6 weeks
● Intentional CO poisoning requires emergency psychiatric consultation in the ED and
eventual follow-up for cognitive dysfunction
● For those with high-risk features of CO intoxication, prior to referral or transport for
hyperbaric oxygen, secure the airway, stabilize vital signs, continue 100% oxygen, and
identify and treat trauma or acute surgical or medical issues.
SPECIAL SITUATIONS
● Delayed Neurological Sequelae(OR Encephalopathy)
● Occur 4 days to 5 weeks after CO exposure
● Reported neurologic effects include cognitive impairments and affective disorders
● The precise neuropathology is not known
● Hyperbaric oxygen has been used anecdotally with success for the treatment of delayed
neurologic sequelae of CO
INFANTS, PREGNANT WOMEN, AND THE ELDERLY
● Infants may be more susceptible to the effects of CO due to the persistence of fetal
hemoglobin for the first 6 months of life, as well as higher metabolic rates.
● The indications for referral of children for hyperbaric oxygen therapy are similar to those
for adults
● Pregnant women should be considered for admitting at a hyperbaric center at CO levels of
15% to 20% because fetal morbidity has been demonstrated at lower levels than usual due
to the high affinity of CO for fetal hemoglobin.
● The elderly, particularly those with serious comorbid disease, are also at higher risk from
CO poisoning.
● In patients with known coronary artery disease, even low levels of COHb (4% to 6%) can
cause ECG changes and myocardial ischemia
● Some elderly may also be at risk due to use of alternative heating sources, particularly
during the winter
THANK YOU

More Related Content

Similar to CARBON MONOXIDE POISONING

Carbonmonoxide poisioning and Its management
Carbonmonoxide poisioning and Its managementCarbonmonoxide poisioning and Its management
Carbonmonoxide poisioning and Its management
sunil kumar daha
 
Co Poisoning
Co PoisoningCo Poisoning
Co Poisoning
Ali Zarezadeh
 
NEUROMONITORING IN ANAESTHESIA
NEUROMONITORING IN ANAESTHESIANEUROMONITORING IN ANAESTHESIA
NEUROMONITORING IN ANAESTHESIA
DrNeelambikaRagate
 
Hydrocarbon Toxicity
Hydrocarbon ToxicityHydrocarbon Toxicity
Hydrocarbon Toxicity
DJ CrissCross
 
Anesthetic consideration in smokers,alcoholics and addicts
Anesthetic consideration in smokers,alcoholics and addictsAnesthetic consideration in smokers,alcoholics and addicts
Anesthetic consideration in smokers,alcoholics and addicts
Aftab Hussain
 
Approach to the poisoned patient part one
Approach to the poisoned patient part oneApproach to the poisoned patient part one
Approach to the poisoned patient part one
Domina Petric
 
Carbon monoxide poisoning. h y aung
Carbon monoxide poisoning. h y aungCarbon monoxide poisoning. h y aung
Carbon monoxide poisoning. h y aung
EhealthMoHS
 
ANESTHETIC CONSIDERATION IN SMOKERS.pptx
ANESTHETIC CONSIDERATION IN SMOKERS.pptxANESTHETIC CONSIDERATION IN SMOKERS.pptx
ANESTHETIC CONSIDERATION IN SMOKERS.pptx
ZIKRULLAH MALLICK
 
Malignant Hyperthermia
Malignant HyperthermiaMalignant Hyperthermia
Malignant Hyperthermia
Chee Oh
 
Carbon monoxide poisoning by dr Yasser Diab
Carbon monoxide poisoning by dr Yasser DiabCarbon monoxide poisoning by dr Yasser Diab
Carbon monoxide poisoning by dr Yasser Diab
Yasser Diab
 
Respiratory acidosis and alkalosis
Respiratory acidosis and alkalosisRespiratory acidosis and alkalosis
Respiratory acidosis and alkalosis
Nikhil Agarwal
 
Inhalational burns injury
Inhalational  burns injuryInhalational  burns injury
Inhalational burns injury
national hosp abuja
 
Burns and anesthesia srk.pptx
Burns and anesthesia srk.pptxBurns and anesthesia srk.pptx
Burns and anesthesia srk.pptx
PratimaSingh928775
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoning
Dhananjay Gupta
 
Organophosphorus poisoning presentation for postgraduate medicine level
Organophosphorus poisoning presentation for postgraduate medicine levelOrganophosphorus poisoning presentation for postgraduate medicine level
Organophosphorus poisoning presentation for postgraduate medicine level
Nausheen57
 
Hypoxia
HypoxiaHypoxia
METHANOL POISONING
METHANOL POISONINGMETHANOL POISONING
METHANOL POISONING
ASHMAL
 
Asphyxiant poisons
Asphyxiant poisonsAsphyxiant poisons
Asphyxiant poisons
Yogesh Ramasamy
 
Asphyxiant poisons
Asphyxiant poisonsAsphyxiant poisons
Asphyxiant poisons
Yogesh Ramasamy
 
Head injury
Head injuryHead injury
Head injury
Antara Banerji
 

Similar to CARBON MONOXIDE POISONING (20)

Carbonmonoxide poisioning and Its management
Carbonmonoxide poisioning and Its managementCarbonmonoxide poisioning and Its management
Carbonmonoxide poisioning and Its management
 
Co Poisoning
Co PoisoningCo Poisoning
Co Poisoning
 
NEUROMONITORING IN ANAESTHESIA
NEUROMONITORING IN ANAESTHESIANEUROMONITORING IN ANAESTHESIA
NEUROMONITORING IN ANAESTHESIA
 
Hydrocarbon Toxicity
Hydrocarbon ToxicityHydrocarbon Toxicity
Hydrocarbon Toxicity
 
Anesthetic consideration in smokers,alcoholics and addicts
Anesthetic consideration in smokers,alcoholics and addictsAnesthetic consideration in smokers,alcoholics and addicts
Anesthetic consideration in smokers,alcoholics and addicts
 
Approach to the poisoned patient part one
Approach to the poisoned patient part oneApproach to the poisoned patient part one
Approach to the poisoned patient part one
 
Carbon monoxide poisoning. h y aung
Carbon monoxide poisoning. h y aungCarbon monoxide poisoning. h y aung
Carbon monoxide poisoning. h y aung
 
ANESTHETIC CONSIDERATION IN SMOKERS.pptx
ANESTHETIC CONSIDERATION IN SMOKERS.pptxANESTHETIC CONSIDERATION IN SMOKERS.pptx
ANESTHETIC CONSIDERATION IN SMOKERS.pptx
 
Malignant Hyperthermia
Malignant HyperthermiaMalignant Hyperthermia
Malignant Hyperthermia
 
Carbon monoxide poisoning by dr Yasser Diab
Carbon monoxide poisoning by dr Yasser DiabCarbon monoxide poisoning by dr Yasser Diab
Carbon monoxide poisoning by dr Yasser Diab
 
Respiratory acidosis and alkalosis
Respiratory acidosis and alkalosisRespiratory acidosis and alkalosis
Respiratory acidosis and alkalosis
 
Inhalational burns injury
Inhalational  burns injuryInhalational  burns injury
Inhalational burns injury
 
Burns and anesthesia srk.pptx
Burns and anesthesia srk.pptxBurns and anesthesia srk.pptx
Burns and anesthesia srk.pptx
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoning
 
Organophosphorus poisoning presentation for postgraduate medicine level
Organophosphorus poisoning presentation for postgraduate medicine levelOrganophosphorus poisoning presentation for postgraduate medicine level
Organophosphorus poisoning presentation for postgraduate medicine level
 
Hypoxia
HypoxiaHypoxia
Hypoxia
 
METHANOL POISONING
METHANOL POISONINGMETHANOL POISONING
METHANOL POISONING
 
Asphyxiant poisons
Asphyxiant poisonsAsphyxiant poisons
Asphyxiant poisons
 
Asphyxiant poisons
Asphyxiant poisonsAsphyxiant poisons
Asphyxiant poisons
 
Head injury
Head injuryHead injury
Head injury
 

Recently uploaded

LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
ShraddhaTamshettiwar
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
Gokuldas Hospital
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
PVI, PeerView Institute for Medical Education
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
Chulalongkorn Allergy and Clinical Immunology Research Group
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Rahul Sen
 
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
Gokuldas Hospital
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
MuhammadMuneer49
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
KerlynIgnacio
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 

Recently uploaded (20)

LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
 
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 

CARBON MONOXIDE POISONING

  • 2. INTRODUCTION ● Carbon Monoxide poisoning occurs after breathing in excessive levels of carbon monoxide ● It is released into the environment by the incomplete combustion of carbonaceous materials
  • 3. EPIDEMIOLOGY ● Carbon Monoxide may be responsible for 50% of all fatal poisonings ● Carbon Monoxide poisoning victims dies before reaching the hospital ,of those hospitalised, approximately 2% die, 10%recovery partially , and 23% to 47% suffer delayed neurologic sequelae
  • 4. SOURCES OF EXPOSURE CO is produced from incomplete combustion of fuels. Potential sources of CO include: ● Smoke inhalation from fires ● Poorly functioning heating systems ● Improperly vented fuel-burning devices ● Motor vehicles operating in poorly ventilated areas ● Open air exposure to motorboat exhaust ● Underground electrical cable fires that produce large amounts of CO, which can seep into adjacent buildings and homes ● Inhaled or ingested methylene chloride
  • 5. PATHOPHYSIOLOGY ● Normal physiologic CO levels (as carboxyhemoglobin) from this process are approximately 1% in healthy nonsmokers. ● Physiologic production can be increased in hemolysis or sepsis. ● CO toxicity causes profound tissue hypoxia and activation of inflammatory mediators that may lead to permanent injury of the heart, the CNS and less commonly, the peripheral nervous system
  • 6. CO enters the body via lungs Direct interactions damages the lung parenchyma In the body CO is delivered by Hb CO causes capillary leakage of macromolecules from the lungs and systemic vasculature This can occur in humans who have been exposed to relatively low concentration
  • 7. As Carboxyhemoglobin(COHgb) levels rises Cerebral blood vessels dilate, and both coronary blood flow and capillary density increases If exposure continues, central respiratory depression develops which may result from cerebral hypoxia Cardiac effects VENTRICULAR arrhythmias occur Ventricular arrhythmias are implicated as the cause of death most often in CO poisoning
  • 8. There is evidence that myocardial impairment begins at the relatively low level of COHgb of 20% The overall cause of death for CO poisoning is combined hypoxia and ischemia during the acute events
  • 9. Tissue hypoxia ● Approx 85% of CO is bound to HB ● Rest dissolve in plasma or bound intracellularly often to myoglobin ● CO shift the oxyhemoglobin dissociation curve to left,imparin 02 release to tissues ● Half life of COHb on RA ranges b/w 249-320 min ● On 100% 02 AP ½ life is about 74-80 min ● ½ life of METHYLENE CHLORIDE exposure > 8 hrs due to metabolic production OXYGEN TENSION 150 mm Hg HbO2 % sat 0 100%
  • 10. Mitochondrial inhibition CO binds as ferrous heme A3 disabling oxidative phosphorylation (more under the hypoxic conditions) ● Decreases adenosine triphosphate production ● production of free radicals ● compromising tissues with the highest metabolic demand(brain & heart) ● generating lactic acidosis
  • 11. CO activates By displacing NO reacts with superoxide Platelets Peroxynitrite Compromise mitochondrial functions Platelets activation To yield further stimulates Inflammatory and platelets effects
  • 12. the combined effect Neutrophil to degenerate Myeloperoxidase further degranulation stimulates releases amplifying & Platelet activation
  • 13. Proinflammatory mediators catalyze Lipid peroxidation of myelin proteins of nerves tissues triggering & microglia (primarily of the CNS) Cells are more sensitive to this neurotoxic effect lymphocytes
  • 14. Demonstrate GLOBUS PALLIDUS lesion Evident in CT/MRI Platelet activation endothelial injury & cell apoptosis combine to yield several types of cardiac injury or dysfunction
  • 15. CARBOXYHEMOGLOBIN MEASUREMENT ● Co-oximetry, which measures total hemoglobin as well as oxyhemoglobin, methemoglobin, and COHb saturation, is the only accurate measurement tool. ● venous blood gas with co-oximetry is sufficient in most cases.
  • 16. TOXICODYNAMICS ● Carbon monoxide has ~210 times the affinity for haemoglobin than oxygen. ● Binding Therefore renders haemoglobin oxygen carrying capacity and delivery to the tissues. ● This can result in tissue hypoxia and ischaemic injury.
  • 17. ● CO also binds to intracellular cytochromes, impairing aerobic metabolism ● Carbon monoxide also triggers endothelial oxidative injury, lipid peroxidation and an inflammatory cascade ● These mechanisms are probably responsible for delayed neurological sequelae
  • 18. Typical clinical symptoms and signs relative to COHb ● <10% (nil, commonly found in smokers) ● 10 – 20% (nil or vague nondescript symptoms) ● 30 – 40% (headache, tachycardia, confusion, weakness, nausea, vomiting, collapse) ● 50 – 60% (coma, convulsions,Cheyne-Stokes breathing, arrhythmias, ECG changes) ● 70 – 80% (circulatory and ventilatory failure, cardiac arrest, death)
  • 19. TOXICOKINETICS ● Absorption: ● COHb concentration in blood is a function of the CO concentration in inspired air and the time of exposure ● Clinical effects occur within 2 hours of exposure at concentrations as low as 0.01% (100 ppm)
  • 20. ● Uptake (and elimination) of CO is increased by: ● Decreased barometric pressure ● increased activity ● increased rate of ventilation ● high metabolic rate ● Anaemia ● Tobacco smokers have higher baseline concentrations of COHb (3 to 10%) and therefore will reach toxic concentrations earlier in any exposure
  • 21. ● Distribution: ● Rapidly binds available haemoglobin
  • 22. ● Metabolism: ● <1% of the absorbed CO is metabolised endogenously to carbon dioxide
  • 23. Elimination: ● CO is eliminated unchanged from the lungs in an exponential manner ● The biological half-life of CO in a sedentary healthy adult is 4–5 hours
  • 24. ● This half-life decreases with oxygen administration ● ~ 40–80 minutes with administration of 100% oxygen ● ~ 23 minutes with hyperbaric oxygen (2 atmospheres) ● elimination is affected by the factors as absorption and is likely faster in many CO poisoned patients due to compensatory measures (e.g. hyperventilation,increased cardiac output)
  • 25. ACUTE POISONING ● CNS:Headache,nausea,dizziness,confu sion,AMS,ataxia,seizures and finally comma ● CVS: Dysrhythmias,Ischaemia,hyper or hypotension ● GI:Abdominal Pain, Nausea+Vomiting, Diarrhoea ● RS: Dyspnea,Tachycardia,Chest Pain, Palpitation CHRONIC POISONING ● Headache ● Personality changes ● Poor Concentration ● Dementia, Psychosis ● Parkinsonism ● Ataxia ● Peripheral Neuropathy and ● Hearing loss CLINICAL FEATURES
  • 26. INVESTIGATIONS ABG: ● HbCO (elevated levels are significant, but low levels do not rule out exposure) ● lactate (tissue hypoxia) ● PaO2 should be normal, SpO2 only accurate if measured (not calculated from PaO2) ● MetHb (exclude) ECG: ● sinus tachycardia, ischaemic changes Urinalysis ● positive for albumin and glucose in chronic intoxication
  • 27.
  • 28. IMAGING Radiographic features: ● Changes tend to be bilateral with the globus pallidus most commonly affected. CT: ● Classically seen as low attenuation in the globus pallidus region. Other features include diffuse hypoattenuation in cerebral white matter.
  • 29. LABORATORY ● CBC (mild leukocytosis) ● BSL (hyperglycaemia) ● UEC (hypokalaemia, acute renal failure from myoglobinuria) ● CK (rhabdomyolysis) ● LFT derangement (ischaemia) ● ethanol level (polypharmacy OD) ● cyanide level (industrial fire, cyanide exposure)
  • 30. TREATMENT LOW-RISK FEATURES ● If CO poisoning is suspected, start 100% oxygen immediately. ● Identify risks for possible referral for hyperbaric oxygen treatment HIGH-RISK FEATURES ● HBO2 [hyperbaric oxygen] therapy or high-flow normobaric therapy for acute CO-poisoned patients
  • 31.
  • 32. ● role is uncertain ● 3 atmospheres will decrease the half life of carboxyHb from 6 hours to ~ 24 minutes often considered for therapy if: ● All pregnant patients ● Significant LOC ● Signs of ischaemia ● Significant neurological deficit ● Metabolic acidosis
  • 33. contra-indications: ● chest trauma ● other major comorbidity or acute instability (e.g. serious drug overdose, severe burns) ● uncooperative patient
  • 34. complications: ● decompression sickness ● rupture of tympanic membranes ● damaged sinuses ● oxygen toxicity ● problems due to lack of monitoring
  • 35. DISPOSITION ● Those without any high-risk features of CO intoxication may be discharged from the ED after symptom resolution and normalization ● If there is a suspected source of environmental CO, other potentially exposed persons should be contacted and evaluated in the ED ● Patients with accidental or inadvertent CO exposure should be referred for cognitive follow-up in 4 to 6 weeks
  • 36. ● Intentional CO poisoning requires emergency psychiatric consultation in the ED and eventual follow-up for cognitive dysfunction ● For those with high-risk features of CO intoxication, prior to referral or transport for hyperbaric oxygen, secure the airway, stabilize vital signs, continue 100% oxygen, and identify and treat trauma or acute surgical or medical issues.
  • 37. SPECIAL SITUATIONS ● Delayed Neurological Sequelae(OR Encephalopathy) ● Occur 4 days to 5 weeks after CO exposure ● Reported neurologic effects include cognitive impairments and affective disorders ● The precise neuropathology is not known ● Hyperbaric oxygen has been used anecdotally with success for the treatment of delayed neurologic sequelae of CO
  • 38. INFANTS, PREGNANT WOMEN, AND THE ELDERLY ● Infants may be more susceptible to the effects of CO due to the persistence of fetal hemoglobin for the first 6 months of life, as well as higher metabolic rates. ● The indications for referral of children for hyperbaric oxygen therapy are similar to those for adults ● Pregnant women should be considered for admitting at a hyperbaric center at CO levels of 15% to 20% because fetal morbidity has been demonstrated at lower levels than usual due to the high affinity of CO for fetal hemoglobin.
  • 39. ● The elderly, particularly those with serious comorbid disease, are also at higher risk from CO poisoning. ● In patients with known coronary artery disease, even low levels of COHb (4% to 6%) can cause ECG changes and myocardial ischemia ● Some elderly may also be at risk due to use of alternative heating sources, particularly during the winter
  • 40.